APA (7th ed.) Citation

Kripp, M., Horisberger, K., Mai, S., Kienle, P., Gaiser, T., Post, S., . . . Hofheinz, R. (2015). Does the addition of cetuximab to radiochemotherapy improve outcome of patients with locally advanced rectal cancer?: Long-term results from phase II trials. Gastroenterology research and practice. https://doi.org/10.1155/2015/273489

Chicago Style (17th ed.) Citation

Kripp, Melanie, Karoline Horisberger, Sabine Mai, Peter Kienle, Timo Gaiser, Stefan Post, Frederik Wenz, Kirsten Merx, and Ralf-Dieter Hofheinz. "Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer?: Long-term Results from Phase II Trials." Gastroenterology Research and Practice 2015. https://doi.org/10.1155/2015/273489.

MLA (9th ed.) Citation

Kripp, Melanie, et al. "Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer?: Long-term Results from Phase II Trials." Gastroenterology Research and Practice, 2015, https://doi.org/10.1155/2015/273489.